Bionano Genomics Stock Quote BNGO - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.7521

Bid

0.7521

Ask

0.756

Volume

987,981

0.75 Day's Range 0.81

0.7143 52 Week Range 8.20

Market Cap

41.567M

Previous Close

0.7872

Open

0.79

Last Trade

0.7521

Last Trade Time

Financial Volume

$ 761,681

VWAP

0.770947

Average Volume (3m)

1,596,601

Shares Outstanding

54,694,000

Dividend Yield

PE Ratio

-0.18

Earnings Per Share (EPS)

-4.25

Revenue

36.12M

Net Profit

-232.49M

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate th... Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.bionanogenomics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Bionano Genomics Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker BNGO. The last closing price for Bionano Genomics was $0.79. Over the last year, Bionano Genomics shares have traded in a share price range of $ 0.7143 to $ 8.20.

Bionano Genomics currently has 54,694,000 shares outstanding. The market capitalization of Bionano Genomics is $41.57 million. Bionano Genomics has a price to earnings ratio (PE ratio) of -0.18.

Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence

Bionano, a global leader in the transformation of the cytogenetic workflow with optical genome mapping (OGM), has entered into a strategic partnership with Hangzhou Diagens Biotechnology Co., Ltd...

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome...

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of...

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to...

Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting

Nine scientific posters will illustrate the application of optical genome mapping (OGM) in cancer research areas including hematological malignancies, solid tumors, and applications in cell and...

Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian...

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System

Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical genome mapping (OGM) and findings from early...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.2579	-25.5346534653	1.01	1.03	0.7143	2107978	0.86025773	CS
4	-0.3079	-29.0471698113	1.06	1.17	0.7143	1800150	0.97868013	CS
12	-0.4579	-37.8429752066	1.21	1.35	0.7143	1596601	1.10024234	CS
26	-1.1179	-59.7807486631	1.87	2.27	0.7143	1636151	1.36198845	CS
52	-6.6139	-89.7895737171	7.366	8.2	0.7143	4046147	5.40575681	CS
156	-53.6479	-98.6174632353	54.4	91.2	0.7143	7689136	33.84009166	CS
260	-41.2479	-98.2092857143	42	156.85	0.7143	11483503	42.1781458	CS

Symbol	Price	Vol.
TWGTop Wealth Group Holding Ltd	$ 3.73 (101.62%)	36.52M
CSLRComplete Solaria Inc	$ 0.465319 (75.59%)	16.64M
SHOTWSafety Shot Inc	$ 0.48 (60.00%)	6.71k
EGOXNext e GO NV	$ 0.0515 (43.06%)	333.3M
MNDRMobile health Network Solutions	$ 27.2386 (33.72%)	10.35M
YYAIConnexa Sports Technologies Inc	$ 0.8943 (-57.21%)	13.4M
SBFMSunshine Biopharma Inc	$ 1.77 (-46.69%)	11.9M
GTIGraphjet Technology	$ 6.43 (-33.09%)	95.33k
ISPCiSpecimen Inc	$ 0.2883 (-31.52%)	2.86M
BGLCBioNexus Gene Lab Corporation	$ 0.5998 (-29.32%)	735.88k
EGOXNext e GO NV	$ 0.0515 (43.06%)	333.3M
SQQQProShares UltraPro Short QQQ	$ 12.84 (6.38%)	219.91M
AGBAAGBA Group Holding Ltd	$ 1.255 (21.84%)	128.79M
TQQQProShares UltraPro QQQ	$ 49.48 (-6.20%)	125.4M
SINTSiNtx Technologies Inc	$ 0.0414 (3.50%)	109.94M

Symbol

Price

Vol.